Abstract

Bone-related malignancies, such as osteosarcoma, Ewing’s sarcoma, multiple myeloma, and cancer bone metastases have similar histological context, but they are distinct in origin and biological behavior. We hypothesize that a distinct immune infiltrative microenvironment exists in these four most common malignant bone-associated tumors and can be used for tumor diagnosis and patient prognosis. After sample cleaning, data integration, and batch effect removal, we used 22 publicly available datasets to draw out the tumor immune microenvironment using the ssGSEA algorithm. The diagnostic model was developed using the random forest. Further statistical analysis of the immune microenvironment and clinical data of patients with osteosarcoma and Ewing’s sarcoma was carried out. The results suggested significant differences in the microenvironment of bone-related tumors, and the diagnostic accuracy of the model was higher than 97%. Also, high infiltration of multiple immune cells in Ewing’s sarcoma was suggestive of poor patient prognosis. Meanwhile, increased infiltration of macrophages and B cells suggested a better prognosis for patients with osteosarcoma, and effector memory CD8 T cells and type 2 T helper cells correlated with patients’ chemotherapy responsiveness and tumor metastasis. Our study revealed that the random forest diagnostic model based on immune infiltration can accurately perform the differential diagnosis of bone-related malignancies. The immune microenvironment of osteosarcoma and Ewing’s sarcoma has an important impact on patient prognosis. Suppressing the highly inflammatory environment of Ewing’s sarcoma and promoting macrophage and B cell infiltration may have good potential to be a novel adjuvant treatment option for osteosarcoma and Ewing’s sarcoma.

Highlights

  • The tumor immune microenvironment shapes tumorigenesis and development (Wu and Dai, 2017) and the diagnosis, treatment, and prognosis of tumor patients (Chen and Mellman, 2013; Clara et al, 2020)

  • The ES score of B cells was significantly elevated in MM, but not in OS, Ewing’s sarcoma (EW), or bone metastases (BM)

  • BM has relatively low infiltration of various T cells, B cells, and plasmacytoid dendritic cells, which is consistent with the prevailing knowledge of the suppressive immune microenvironment in bone metastatic cancer

Read more

Summary

Introduction

The tumor immune microenvironment shapes tumorigenesis and development (Wu and Dai, 2017) and the diagnosis, treatment, and prognosis of tumor patients (Chen and Mellman, 2013; Clara et al, 2020). Studies have indicated that there is a high rate of misdiagnosis and missed diagnosis of OS based on imaging and medical history, especially in elderly patients, with an incident rate of 23–43% (Chen and Mellman, 2013; Wu and Dai, 2017; Clara et al, 2020). The use of the immune microenvironment in bone-associated tumors for diagnosis and prognosis has significant clinical potential

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call